GSK2141795
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for GSK2141795, covering 2017-11-09 to 2022-03-02. Get the full timeline:
Most recent: Clinical Trial Update: Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]